Why the study?
Fetal atrial flutter is uncommon, accounting for about 30% of fetal tachyarrhythmias, and is associated with structural heart anomalies, hydrops, and a 10% fetal mortality rate.
Postnatal electrocardioversion can be successfully used to manage fetal atrial flutter presenting at term.
Supports MDT feasibility for term fetal AF with postnatal cardioversion; hypothesis-generating, should not yet change practice.
Fetal Atrial flutter (AF) is an uncommon condition accounting for about 30% of all fetal tachyarrhythmias. It is associated with structural heart anomalies and hydrops, with 10% fetal mortality rate. This case demonstrates a successfully managed atrial flutter at term with postnatal electrocardioversion using multidisciplinary team approach.
No takes yet. Share an insight, caveat, or question.
Igbokwe et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: